Comparative study on the effects of type 1 and type 2 diabetes on structural changes and hormonal output of the adrenal cortex in male Wistar rats

Journal of Diabetes and Metabolic Disorders

Volumn 12, Issue 1, 2013, Pages

  Elahi Moghaddam, Zohreh ^a   Behnam Rassouli, Morteza ^b   Mahdavi Shahri, Naser ^b   Hajinejad Boshroue, Roya ^a   Khajouee, Elaheh ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Adrenal; Rat; Type 1 diabetes; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ALLOXAN; DRINKING WATER; FRUCTOSE;

ADRENAL CORTEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STEREOLOGY; TRIACYLGLYCEROL BLOOD LEVEL; ADRENAL DISEASE; ALLOXAN-INDUCED DIABETES MELLITUS; BLOOD ANALYSIS; EXPERIMENTAL DIABETES MELLITUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;

EID: 84882739493     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-12-9     Document Type: Article

References (28)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:37-42. American Diabetes Association.
2. Alrefai H, Allababidi H, Levy S, Levy J. The endocrine system in diabetes mellitus. Endocrine 2002, 18:105-119. 10.1385/ENDO:18:2:105, 12374457.
3. Edwards JE, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008, 120:1-34. 10.1016/j.pharmthera.2008.05.005, 18616962.
4. Barber M, Kasturi BS, Austin ME, Patel KP, Mohankumar SM, Mohankumar PS. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res 2003, 964:128-132. 10.1016/S0006-8993(02)04091-X, 12573521.
5. Chiodini I, Lembo SD, Morelli V, Epaminonda P, Coletti F, Masserini B, et al. Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism Clinical and Experimental 2006, 55:1135-1140. 10.1016/j.metabol.2006.04.010, 16839852.
6. Chan O, Inouye K, Riddell MC, Vranic M, Matthews SG. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol 2003, 28:87-102.
7. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 2007, 275:43-61. 10.1016/j.mce.2007.05.015, 17624658.
8. Verges B. Lipid disorders in type 1 diabetes. Diabetes Metab 2009, 35:353-360. 10.1016/j.diabet.2009.04.004, 19733492.
9. Rivellese AA, Vaccaro O, Patti L. The pathophysiology of lipid metabolism and diabetes. Int J Clin Practice 2004, 58:32-35.
10. Jalal R, Bagheri SM, Moghimi A, Behnam-Rasouli M. Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance. Clinical Biochemistry and Nutrition 2007, 41:218-223.
11. Feletou M, Boulanger M, Staczek J, Broux O. Fructose diet and VEGF-induced plasma extravasation in hamster cheek pouch. Acta Pharmacol 2003, 24:207-211.
12. Duncan MH, Singh BM, Wise PH, Carter G, Alagh band-zadeh J. Asimple measure of insulin resistance. Lancet 1995, 346:120-121. 10.1016/S0140-6736(95)92143-5, 7603193.
13. Zahiri SH, Dezfoulian A, Panjeh-Shahin MR, Mambini M, Dehghani F. Study of stereological method in nephrotoxcicty of Cisplatin, the anti-neoplastic drug, in male rats. Journal of Mazandaran University of Medical Sciences 2003, 12(37):1-10.
14. Chan O, Chan S, Inouye K, Vranic M, Matthews SG. Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effects of insulin treatment. Endocrinology 2001, 142:4872-4879. 10.1210/en.142.11.4872, 11606455.
15. Inouye K, Chan O, Riddell MC, Akirav E, Matthews SG, Vranic M. Mechanisms of impaired hypothalamic-pituitary-adrenal (HPA) function in diabetes: reduced counter regulatory responsiveness to hypoglycaemia. Diabetes Nutr Metab 2002, 15:348-355.
16. Noguchi S, Ohno Y, Aoki N. Adrenocortical insufficiency in otsuka long-evanstokushima fatty rats, a type 2 diabetes mellitus model. Metabolism 2007, 56:1326-1333. 10.1016/j.metabol.2007.05.021, 17884440.
17. Dullaart RP, Ubels FL, Hoogenberg K, Smit AJ, Pratt JJ, Muntinga JH, et al. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. Clinical Endocrinology & Metabolism 1995, 80:3002-3008. 10.1210/jc.80.10.3002, 23378455.
18. Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Dilembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 2007, 30:83-88. 10.2337/dc06-1267, 17192338.
19. Revsin Y, Wijk D, Saravia FE, Oitzl MS. Adrenal hypersensitivity precedes chronic hypercorticism in streptozotocin-induced diabetes mice. Endocrinology 2008, 149:3531-3539. 10.1210/en.2007-1340, 18420743.
20. Biessels GJ, Van der heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur Pharmacol 2002, 441:1-14.
21. Golden SH, Malhotra S, Wand GS, Brancati FL, Ford D, Ford D, Horton K. Adrenal gland volume and dexamethasone-suppressed cortisol correlate with total daily salivary cortisol in African-American women. Clinical Endocrinology & Metabolism 2007, 92:1358-1363. 10.1210/jc.2006-2674, 23378455.
22. Saravia F, Gonzales S, Roig P, Alves V, Homo-delarche F, De nicola AF. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell Mol Neurobiol 2001, 21:15-27. 10.1023/A:1007165127420, 11440195.
23. Bisht S, Sisodia SS. Anti-hyperglycemic and antidyslipidemic potential of azadirachtaindica leaf extract in STZ- Induced diabetes mellitus. Pharm Sci Res 2010, 2:622-627.
24. Ganesh T, Saikat S, Thamotharan G, Loganathan T. Pharmacognostic and anti-hyperglycemic evaluation of lantana camara (L.) var. aculeate leaves in alloxan-induced hyperglycemic rats. Int J Res Pharm Sci 2010, 1:247-252.
25. Daniele SM, Montenegro SM, Tarres MC, Picena JC, Martinez SM. The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver. Diabetology Metabolic Syndrom 2010, 2:2-15.
26. Olatunji LA, Okwusidi JI, Soladoye AO. Antidiabetic effect of Anacardiumoccidentale stem-bark in fructose-diabetic rats. Pharm Biol 2005, 43:589-593.
27. Goldberg IJ. Diabetic dyslipidemia. Clin Endocrinol Metab 2001, 96:965-971.
28. Haemmerle G, Zimmermann R, Strauss JG, Kratky D, Riederer M, Knipping G, et al. Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. Biol Chem 2002, 277:12946-12952.